SCHEMBL22157199

SCHEMBL22157199

N#Cc1cc(-n2c3ccc(-c4cccc(-c5ccccc5)n4)cc3c3cc(-c4cccc(-c5ccccc5)n4)ccc32)c(-n2c3ccc(-c4cccc(-c5ccccc5)n4)cc3c3cc(-c4cccc(-c5ccccc5)n4)ccc32)cc1-c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 3/20 0.42
KDM4E B2RXH2 4/20 0.34
NPSR1 Q6W5P4 3/20 0.34
HPGD P15428 3/20 0.34
RXFP1 Q9HBX9 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
RAB9A P51151 2/20 0.34
MAPT P10636 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
SQOR Q9Y6N5 1/20 0.33
DHODH Q02127 1/20 0.33
NR3C1 P04150 1/20 0.33
TGFBR1 P36897 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22157205 0.97 CYP11B1 (0.40) CYP11B1CYP11B2KDM4ENPSR1HPGD
SCHEMBL22156410 0.93 CYP11B1 (0.41) CYP11B1CYP11B2KDM4ENPSR1HPGD
SCHEMBL22157200 0.92 CYP11B1 (0.42) CYP11B1CYP11B2KDM4ENPSR1HPGD
SCHEMBL22157197 0.91 CYP11B1 (0.40) CYP11B1CYP11B2KDM4ENPSR1HPGD
SCHEMBL22157109 0.89 CYP11B1 (0.38) CYP11B1CYP11B2HPGDDHODHNR3C1
SCHEMBL22158523 0.89 CYP11B1 (0.42) CYP11B1CYP11B2KDM4ENPSR1HPGD
SCHEMBL22157030 0.87 CYP11B1 (0.34) CYP11B1CYP11B2KDM4EHPGDRXFP1
SCHEMBL22157032 0.87 SLC6A9 (0.38) CYP11B1CYP11B2KDM4ENPSR1HPGD
SCHEMBL20624331 0.87 AR (0.38) CYP11B1CYP11B2KDM4ENPSR1HPGD
SCHEMBL22156577 0.86 CYP11B1 (0.36) CYP11B1CYP11B2NPSR1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 CYP11B1 827/4885CYP11B2 531/4885KDM4E 4239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.